Western blot analysis of αSMA revealed that the treatment of IPF patient-derived fibroblasts resulted in a significantly elevated expression of αSMA relative to vehicle-treated control (Figure 2B and C). This evidence concerns the gene ACTA1 and idiopathic pulmonary fibrosis.